Document is current
Any future updates will be listed below
-
Authors
Altunay, Betül
Obradović, Luka
Florea, Alexandru
Vogg, Andreas T. J.
Schäfer, Laura
Morgenroth, Agnieszka
Meszaros, Levente K.
Hertel, Fabian
Juweid, Malik E.
Mottaghy, Felix M.
-
Funding
Funding for this research was provided by:
Universitätsklinikum RWTH Aachen
- License Information
-
More Information
Article History
Received: 24 July 2025
Accepted: 23 October 2025
First Online: 4 November 2025
Declarations
:
: LM is an employee Radiopharm Theranostics. F.M.M. is a medical advisor and consultant for Advanced Accelerator Applications (AAA) GmbH/Novartis, Telix Pharmaceuticals, and CURIUM TM, and has recently received institutional grants from NanoMab Technology Ltd., Radiopharm Ltd., Siemens Healthcare, and GE Precision Healthcare LLC. All other authors have no relevant financial or non-financial interests to disclose.
: All animal experiments were approved by a German competent authority (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen) for compliance with the Animal Protection Act, in conjunction with the regulation for the protection of animals used for experimental and other scientific purposes.
